Drawing for SIGHTNOVO

USPTO serial 79306285

SIGHTNOVO

Reviewed by CopyMark Law Group

Reg. 6696100Status 700Registered
Filing date
Status date
Registration date
Apr 12, 2022
Examiner
MESSICK, TABITHA LEE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SIGHTNOVO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nazly Aileen Bayramoglu

Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC1540 West Warm Springs Road Suite 100Henderson, NV 89014UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Chemico-pharmaceutical preparations for use in the diagnosis and accurate treatment of ophthalmic diseases; diagnostic biomarker reagents for medical purposes; dietetic substances in the nature of beverages adapted for medical use; dietetic foods adapted for medical purposes; diagnostic preparations for medical purposes; reagent paper for medical purposes; pre-filled syringes for medical purposes with triamcinolone acetonide suspension and dexamethasone suspension; pharmaceutical preparations for use in the diagnosis and accurate treatment of ophthalmic diseases; nutraceutical preparations for therapeutic or medical purposes for treatment of ophthalmic diseases; nutritional supplementsACTIVE—
010Medical apparatus and instruments for diagnosing, treating, and preventing ophthalmic diseases; cases fitted for medical instruments; syringes for injections; hypodermic syringes; syringes for medical purposes; injectors for medical purposes, namely, medical fluid injectors; medical diagnostic apparatus for testing for viruses; medical diagnostic apparatus for analyzing electrolytes in the body; Medical diagnostic apparatus for detecting cancer; needles for medical purposesACTIVE—
044Hospital services; services of a psychologist; nutritional therapy services, mental health therapy services; telemedicine services; health counselling; health care; nursing, medical; medical equipment rental; medical clinic servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 26, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Aug 26, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 12, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 12, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jan 5, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 5, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 18, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 13, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2021RFNTREFUSAL PROCESSED BY IB—
Jul 20, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 20, 2021RFRRREFUSAL PROCESSED BY MPU—
Jul 3, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 2, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2021DOCKASSIGNED TO EXAMINER—
Mar 19, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 11, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance